| Literature DB >> 16637253 |
Takashi Fukunaga1, Hirofumi Soejima, Koichi Sugamura, Sunao Kojima, Seigo Sugiyama, Tomohiro Sakamoto, Michihiro Yoshimura, Toshihide Tanoue, Toshiro Kageshita, Tomomichi Ono, Hisao Ogawa.
Abstract
A 61-year-old woman with stage IV malignant melanoma suffered acute myocardial infarction during the third course of chemotherapy with cisplatin, dacarbazine, nimustine hydrochloride and tamoxifen citrate, despite no serious problem occurring during the first and second courses of chemotherapy. Since this patient, excluding menopause, had no significant risk factor for coronary heart disease before the start of chemotherapy, the infarction was likely to be attributable to the chemotherapy regimen. Chemotherapy should be used cautiously in patients with coronary risk factors before treatment is begun.Entities:
Mesh：
Substances：
Year: 2006 PMID： 16637253
Source DB: PubMed Journal: J Cardiol ISSN： 0914-5087 Impact factor: 3.159